Candela, your trusted partner
in energy-based medical aesthetics.
Corporate Overview
The Candela
difference
Candela is a leading global medical aesthetic device company with a comprehensive
product portfolio and global distribution footprint in over 100 countries. With hundreds
of patents issued around the world, we’re dedicated to the development of innovative,
quality products that allow treatment providers to offer advanced solutions for a broad
range of medical aesthetic applications.
Leading by experience,
growing by design
For 50 years, Candela has been a leading provider in the medical aesthetic market. In this fast growing
and dynamic landscape, Candela stands apart by anticipating the demands of practitioners around the
globe. Candela provides an extensive product portfolio with technology that offers a wide range
of advanced solutions that improve a wide range of medical and aesthetic dermatologic conditions.
We strive to continually deliver on our legacy of innovation, backed by solid science and clinical
evidence, to be recognized as the most trusted partner in energy-based medical aesthetics.
15% Potential growth of energy-based
device segments through 2023 †
# 1 Dermatologist
recommended energy
device brand*
$ 18 Billion
$ 3.4 Billion Estimated industry opportunity †
*Based on research conducted by Wizer, a Nielsen Innovate company.
†Global Aesthetic Market XVIII July 2019 Report, Medical Insights, Inc.;
growth rates vary across energy-based device segments
Our promise
Science. Results. Trust.
Candela delivers what today’s practitioners value most – Science. Results. Trust – core pillars for
users of energy-based devices to ensure the health of their practices and their patients. Sharing
equal importance across the organization, these pillars are the founding principles for which our
company was built and the standards for which we hold ourselves accountable. Collectively,
they are what make us Candela.
~50,000 Install base
Forecasted yearly spend on energy-based 315+ Granted patents and patent applications
procedures by 2023 †
Global reach in 100+ countries
Science-driven commitment
At Candela, our roots run deep in scientific research and development. We bring a
pioneering spirit to the medical aesthetic device industry, which began nearly 50 years
ago when Candela first began developing custom lasers to the scientific community.
Today, our research teams are comprised of industry recognized and respected
scientists who are the driving force behind perfecting the technology that paves
the way for new and innovative products.
Transformational science
With research hubs across three continents, Candela is uniquely positioned with a truly global view on
the industry and how energy-based science can be applied across diverse populations. Our research
teams are closely connected to our customers and global commercial teams, and we directly align the
needs of our customers and their patients to drive our approach to innovation.
We have long been at the forefront of science and technology. From conceptual, cutting-edge
applications to innovative firsts, our approach to science has delivered breakthrough technologies that
have had a significant impact on the industry.
To enhance the investment our customers make in our technology platforms, our research teams
innovate to expand the capabilities of existing platforms, to continually drive incremental value to our
customers and the patients they treat.
Candela science drives:
Industry leading development of energy-based devices such as the Vbeam platform to
•
treat vascular lesions and the Gentle family of products for hair removal and more
The advancement of technologies like the picosecond laser technology with devices
•
such as PicoWay®
• Integrated cooling technology with the Dynamic Cooling Device (DCD™) cooling system,
still the gold standard for patient comfort and safety
• Progress for treating diverse skin types
Results-focused reliability
Candela stands proudly behind its commitment to deliver results – the results our
customers expect and the results their patients deserve. Every device, handpiece
and accessory we manufacture not only meets the industry regulatory standards, but
also Candela quality standards for which we hold ourselves accountable to ensure
optimal outcomes. Every day, across the world, thousands of customers confidently use
their Candela products, knowing they are backed by science and clinical evidence.
Clinical excellence
A commitment to clinical evidence starts in our research labs and quickly moves to the Candela
Institute for Excellence (CIE), our state-of-the-art clinical facility. At CIE, experienced clinicians begin to
test and study early ideas. Clinical trials are developed, analyzed and results are published in a variety
of forums – peer reviewed journals, academic presentations, white papers and case reports.
Outside of Candela, a vibrant network of physician owned Centers of Excellence (CoEs), work closely
with our internal teams on expanding and refining treatment protocols, testing products, educating
physicians and completing the connection to innovation and patient outcomes.
Candela results have provided:
Hundreds of physician authored peer reviewed clinical papers published in leading medical
•
journals over the decades that inspire confidence in our vision for medical aesthetic solutions
A vast library of captivating before and after photos that cross gender, age and skin types
•
from around the globe
• old standard platforms such as the Vbeam system for the treatment of vascular lesions and
G
the Gentle series for hair removal that continue to be preferred worldwide
A growing number of Candela Centers of Excellence advancing education worldwide
•
Trust-based collaboration
Putting our words into action, we stand by our Candela Commitment. This robust program
allows us to support our customers and their patients though a full spectrum of services
from clinical training, ongoing education, technical support and customer service. We want
to give our customer every resource as they care for the health of their patients and their
practice. It is simple. Our customer’s success is our success.
Unparalleled commitment
Trust may be a small word, but it is a big reason why Candela is unique. Trust is earned. That is why we work
hard every day for our customers. By truly listening to what practitioners want for their practice and their
patients, Candela has built a responsive program that can uniquely support practices to help them grow.
This is our Candela Commitment.
Going beyond the sale of our devices, the Candela Commitment encompasses the value-added services
that keep practitioners as Candela customers for years to come. With unmatched service, comprehensive
marketing and continuous clinical training opportunities, customers trust that Candela is there with the
support and resources they need to perform at their best.
Trust is what connects people to Candela, not only through our customer-focused programs but also through
our work within the industry. Candela is dedicated to leading the industry through continuous open dialogue,
knowledge sharing and working with peers to explore the frontiers of what is possible in aesthetic medicine.
Candela focus on trust includes:
Collaborating with our customers across medical specialties to build solutions that
•
address the needs of their patients
Continued investments in clinical education and training, marketing and awareness drivers
•
and service support to provide full partnership to our customers
Dedication to building strong global partnerships and global presence
•
Innovating firsts that last.
1986
1970
1993
FDA clearance is received for
the STPL 1 device, the first
pulsed dye laser, leading to the
development of the industry’s
gold standard for vascular
Candela is founded as an The first Q-switched technology
treatments
industrial laser company in is launched for the treatment
Wayland, Massachusetts, USA of unwanted tattoos and
pigmented lesions
1998
First pulsed-dye laser based
on the theory of selective
photothermolysis is developed
1983
2002
2012
Smoothbeam® 1450 nm diode The GentleMax Pro® device is
laser is launched for the introduced, combining the 755 nm
treatment of acne vulgaris, acne alexandrite and 1064 nm Nd:YAG
scars, and periorbital wrinkles lasers.
The first focused pulsed ultrasound
device, the UltraShape® system, is
2000
added to the portfolio
2011
The elos® technology is
developed combining optical
and infrared (IR) energies and
radiofrequency (RF) technologies
GentleLase® system is launched.
2004
2015
The VelaShape® I system is The Profound® system, the first tempera-
introduced, the first system ture-controlled RF microneedling device
incorporating RF and IR for is commercialized.
the temporary improvement
The PicoWay® 2-wavelength laser
of cellulite.
platform is introduced.
2012
2019
2004
UltraShape Ltd. acquired Candela rebrands globally
Syneron goes public
2017
2010
Apax Partners acquires Candela
Candela and Syneron merge
2018
Candela acquires Ellipse
The Alexandrite
laser is FDA cleared The CO2RE® system is launched.
for permanent hair
2009
reduction
The third wavelength and the
Resolve module for the PicoWay
device are introduced.
The CO2RE Intima® module for
The Vbeam Perfecta device, a
® women’s health is launched
2016
world leader in the treatment of
vascular lesions, is introduced.
2005
The elos Plus®, eMatrix®, and eTwo®
systems are introduced with RF
technology for aesthetic applications.
Launch of the Alex TriVantage system
2008
Social responsibility
At Candela we do more than just help people to look and feel their best. We are
committed to developing innovative, transformational technologies that treat
serious afflictions impacting individuals regardless of age and skin type from
around the globe. With these treatments, we are transforming lives. That is why
we partner with some of the world’s most respected charitable organizations
that share our belief in changing lives.
Candela devices are changing lives around the globe. They are
used to treat vascular birthmarks in young children, administer
scar therapy in wounded veterans, and treat survivors of domestic
abuse. These are just a few of the life changing applications. From
our work with the Vascular Birthmark Foundation to the American
Academy of Facial Plastic and Reconstructive Surgery (AAFPRS),
Candela goes beyond just improving looks.
We are committed to transforming lives.
A complete portfolio of innovative technologies
for aesthetic solutions for both the face and body.
Nordlys™ Frax Pro™ Sirius™
Foundational platform with SWT®, Frax Expandable, 1550 nm non-ablative Multi-application platform with patented,
1550 and Nd:YAG 1064 nm technologies fractional laser system for skin narrowband SWT™ technology with dual
resurfacing filters for photorejuvenation, hair removal,
and facial veins
Gentle Pro Series™ VelaShape® III Vbeam® Series
755 nm and 1064 nm lasers for IR & RF technology for cellulite Premier pulsed dye laser for vascular
laser hair removal, vascular and skin and thigh circumference reduction and dermatological conditions
treatments
Exceed™
Medical microneedling device to treat acne-scars
PicoWay® Profound® CO2RE® and CO2RE Intima®
True picosecond laser for benign Single treatment temperature controlled Versatile CO2 laser platform for surgical
pigmented lesions and tattoo removal RF microneedling for facial wrinkles procedures in the area of dermatology,
with 3 wavelengths - 532 nm, 785 nm plastic surgery and treatment of vaginal
and 1064 nm atrophy and rejuvenation
Alex TriVantage® elōs Plus® eTwo®
Pigmented lesion & tattoo removal Complete aesthetic workstation Desktop device for resurfacing
treatments and wrinkles
Over 10 million treatments performed
annually with our products.
Energy-based medical
aesthetics built on
Science.
Results.
Trust.
Disclaimer: All contents of this material are for informational purposes only and provided by Candela without warranties of any kind. Healthcare professionals are solely responsible for making their own
independent evaluation as to the suitability of any product for any particular purpose and in accordance with country specific regulations. The availability of products and the indications mentioned in this
material is subject to the regulatory requirements and product registration status in each country. Refer to the User Manual for country specific indications. Products and technical specifications may change
without notice. Please contact Candela for more details.
©2020 Candela Corporation. This material contains registered and unregistered trademarks, trade-names, service marks and brand names
of Candela Corporation and its affiliates. All other trademarks are the property of their respective owners. All rights reserved.
PU00946EN, Rev. A
